Iron Regulatory Proteins Secure Mitochondrial Iron Sufficiency and Function  by Galy, Bruno et al.
Cell Metabolism
Short ArticleIron Regulatory Proteins Secure
Mitochondrial Iron Sufficiency and Function
Bruno Galy,1 Dunja Ferring-Appel,1 Sven W. Sauer,2 Sylvia Kaden,3 Saı¨d Lyoumi,4,5 Herve Puy,4,5 Stefan Ko¨lker,2
Hermann-Josef Gro¨ne,3 and Matthias W. Hentze1,*
1European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany
2Department of General Pediatrics, Division of Inherited Metabolic Disease, University Children’s Hospital Heidelberg,
Im Neuenheimer Feld 430, 69120 Heidelberg, Germany
3Deutsches Krebsforschungszentrum Heidelberg, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
4Centre Franc¸ais des Porphyries, Hoˆpital Louis Mourier, 178 rue des Renouillers, 92701 Colombes CEDEX, France
5INSERM Unite´ 773, Centre de Recherches Biome´dicales Bichat-Beaujon, Universite´ de Versailles Saint-Quentin en Yvelines,
75018 Paris, France
*Correspondence: hentze@embl.de
DOI 10.1016/j.cmet.2010.06.007SUMMARY
Mitochondria supply cells with ATP, heme, and iron
sulfur clusters (ISC), and mitochondrial energy
metabolism involves both heme- and ISC-dependent
enzymes. Here, we show that mitochondrial iron
supply and function require iron regulatory proteins
(IRP), cytosolic RNA-binding proteins that control
mRNA translation and stability. Mice lacking both
IRP1 and IRP2 in their hepatocytes suffer from mito-
chondrial iron deficiency and dysfunction associated
with alterations of the ISC and heme biosynthetic
pathways, leading to liver failure and death. These
results uncover amajor role of the IRPs in cell biology:
to ensure adequate iron supply to the mitochondrion
for proper function of this critical organelle.
INTRODUCTION
Maintenance of cellular and organismal iron balance requires
adequate iron uptake and prevention of toxic iron excess
(Andrews, 2008). At the systemic level, the hepatic ‘‘iron
hormone’’ hepcidin (Hamp) has emerged as the key regulator
of blood iron levels (Nemeth and Ganz, 2006). At the cellular
level, in vitro and cell culture studies have shown that IRP-1
and –2 enact posttranscriptional regulation of critical iron
metabolism genes via their interaction with cis-regulatory iron-
responsive elements (IRE) present on target mRNAs, especially
for the transferrin receptor, the iron storage protein ferritin, and
the iron exporter ferroportin (FPN)/SLC40A1 (Muckenthaler
et al., 2008; Wallander et al., 2006). However, the overarching
biological function(s) of the IRP/IRE regulatory network in cellular
physiology remain(s) to be defined.
Mouse models of IRP deficiency have recently become avail-
able to explore the in vivo functions of the IRP/IRE system (Galy
et al., 2005a; LaVaute et al., 2001; Meyron-Holtz et al., 2004).
Whereas mice with systemic deficiency for either IRP are viable
and fertile (Galy et al., 2005b), doubly deficient animals die during
early embryogenesis (Galy et al., 2008; Smith et al., 2006),
showing that the IRP/IRE system is essential and that the two194 Cell Metabolism 12, 194–201, August 4, 2010 ª2010 Elsevier IncIRPs are functionally redundant. The lethality of mice with
compound IRP deficiency combined with strong functional
redundancy between the two proteins poses a challenge to
elucidating the IRPs’ cell biological function(s).
To bypass this problem, we simultaneously ablated IRP1 and
IRP2 in a tissue-specific manner using Cre/Lox technology
(Garcia and Mills, 2002). We inactivated the Aco1 and Ireb2
genes in hepatocytes, the major storage depot for excess iron
in the body and the source of the systemic iron hormone
hepcidin (Graham et al., 2007). Our study shows that the IRP/IRE
system plays a critical role for mitochondrial iron management
and function and is essential for liver physiology and organismal
survival.RESULTS AND DISCUSSION
Hepatocytic IRP Deficiency Causes Lethal Liver Failure
Mice homozygous for floxed Aco1 and Ireb2 alleles (Aco1flox/flox,
Ireb2flox/flox) (Galy et al., 2008) were bred to a transgenic line
(Alfp-Cre) expressing Cre recombinase under the control of
the Albumin/afetoprotein regulatory elements selectively in
hepatocytes, starting at E9.5–E10.5 (Kellendonk et al., 2000).
Aco1flox/flox,Ireb2flox/flox,Alfp-Cre animals (IrpAlfp-Cre(+)) are born
at nearly Mendelian ratios (see Table S1 available online) and
are macroscopically indistinguishable from control littermates
lacking the Alfp-Cre transgene (IrpAlfp-Cre()) at birth; however,
all IrpAlfp-Cre(+) mice die between 8 and 12 days postpartum
(p.p.) (Figure 1A and Table S1). Southern blotting ascertained
liver-specific Cre recombination of the floxed Irp alleles
(Figure S1). At 8 days p.p., IrpAlfp-Cre(+) mice appear wasted
(Figure 1B), with a 25% reduction of body weight (Figure 1C).
Although hepatic Hepcidin expression is downregulated to
30% of control levels (Figure S2), hematological and blood
chemistry parameters reveal no sign of systemic iron abnormal-
ities (Table 1); Hepcidin downregulation in the context of
unchanged transferrin saturation is unexpected and could plau-
sibly be due to cellular damage and/or intracellular iron depletion
(see below and Figure S2). Serum ferritin levels are elevated,
possibly due to secretion from IRP-deficient hepatocytes that
overexpress ferritin (Figure S3) and/or release into the blood-
stream as a consequence of cell damage (see below)..
Figure 1. Liver Failure and Early Death of Mice with Complete Hep-
atocytic IRP Deficiency
(A) Kaplan-Meyer survival curves showing preweaning lethality of IrpAlfp-Cre(+)
mice (red curve) compared to IrpAlfp-Cre() littermates (black curve).
(B) Mice with hepatocytic IRP deficiency (red arrow) at 8 days of age; an
IrpAlfp-Cre() control littermate lacking Cre recombinase expression is also
shown.
(C) Body weight, box-plot representation with minimal to maximal values.
(D) Enlargement and fatty appearance of the liver in 8-day-old IrpAlfp-Cre(+)
animals (red arrow) compared to control.
(E and F) (E) Liver weight (square root of 100 3 [liver weight/body weight])
and (F) hepatic triglyceride (TG) content. Data are presented as means ±
SEM. The sample size (n) is indicated; p values were determined by
Student’s t test.
Table 1. Hematological and Blood Chemistry Parameters of Mice
Lacking Both IRP1 and IRP2 in Hepatocytes
IrpAlfp-Cre() n IrpAlfp-Cre(+) n p
Blood Chemistry
Plasma Fe (mmol/l) 41.8 ± 4.8 16 46.3 ± 11.1 12 0.717
UIBC (mmol/l) 116.0 ± 1.4 16 116.9 ± 1.5 12 0.664
TIBC (mmol/l) 157.8 ± 4.6 16 163.2 ± 10.9 12 0.658
Tf sat. (%) 25.7 ± 2.1 16 25.8 ± 3.6 12 0.968
Ferritin (ng/ml) 86 ± 7 12 4045 ± 448 9 <0.0001
Albumin (g/l) 12.0 ± 0.6 12 10.8 ± 0.4 9 0.132
Total protein (g/l) 31.3 ± 0.5 12 27.0 ± 0.3 9 <0.0001
Total bilirubin (mmol/l) 2.6 ± 0.1 10 45.7 ± 4.9 9 <0.0001
Conj. bilirubin (mmol/l) 0.6 ± 0.2 10 21.0 ± 2.6 9 <0.0001
AP (U/l) 815 ± 43 12 1682 ± 178 9 <0.01
ALT (U/l) 16 ± 1 12 32 ± 4 9 <0.01
AST (U/l) 117 ± 9 12 257 ± 11 9 <0.0001
Hydroxybutyrate (mmol/l) 1.06 ± 0.07 12 0.96 ± 0.26 9 0.262
Hematology
WBC count (109/l) 7.93 ± 0.86 25 7.75 ± 0.74 18 0.698
RBC count (1012/l) 4.54 ± 0.09 25 4.82 ± 0.13 18 0.079
MCV (fl) 62.3 ± 0.7 25 68.1 ± 2.5 18 0.765
RDW (%) 16.4 ± 0.3 25 16.7 ± 0.3 18 0.448
Hemoglobin (g/l) 108 ± 3 25 117 ± 4 18 0.075
Hematocrit (%) 30.6 ± 0.7 25 32.8 ± 0.8 18 0.056
MCH (pg) 23.8 ± 0.6 25 24.8 ± 1.5 18 0.549
MCHC (g/l) 353 ± 8 25 362 ± 19 18 0.658
Platelet count (109/l) 177 ± 48 25 273 ± 42 18 0.142
MPV (fl) 6.44 ± 0.10 25 6.31 ± 0.11 18 0.411
Hematological and blood chemistry parameters of IrpAlfp-Cre(+) versus
IrpAlfp-Cre() mice were determined at 8 days of age. Data are given as
averages ± SEM. The sample size (n) is indicated. p represents the value
of a Student’s t test (unpaired, two-tailed). UIBC, unsaturated-iron
binding capacity; TIBC, total iron-binding capacity; Tf sat., transferrin
saturation; Conj. bilirubin, conjugated bilirubin; AP, alkaline phosphatase;
ALT, alanine aminotransferase; AST, aspartate aminotransferase; WBC,
white blood cell; RBC, red blood cell; MCV, mean corpuscular volume;
RDW, red blood cell distribution width; MCH, mean corpuscular hemo-
globin; MCHC, mean corpuscular hemoglobin concentration; MPV,
mean platelet volume. See also Figure S2 and Table S2.
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CelIrpAlfp-Cre(+) mice display hepatic steatosis (Figure 1D), with
increased liver weight (Figure 1E) and hepatic triglyceride (TG)
levels (Figure 1F); the steatosis is further evident from the pres-
ence of multiple lipid droplets on periodic acid Schiff stains
(Figures 2A to 2D) and on electron micrographs (Figures 2G
and 2H). Normal levels of plasma hydroxybutyrate (Table 1)
and acylcarnitines (Table S2) rule out impaired b-oxidation as
a possible cause of hepatic lipid loading. Normal liver weight
and TG content in Alfp-Cre mice (Figure S1) show that the
hepatic steatosis in IrpAlfp-Cre(+) animals is not an artifact due
to the Alfp-Cre transgene per se (Schmidt-Supprian and
Rajewsky, 2007).(G and H) Signs of internal bleeding in the intestine (G) and the brain (H) of
IrpAlfp-Cre(+) mice (red arrow); a control sample is shown for comparison.
See also Figure S1 and Table S1.
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Figure 2. Histological and Ultrastructural Abnormalities in the Liver
of Mice Lacking Hepatocytic IRP Expression
Histological (A–F) and ultrastructural (G–L) analyses of the liver of 8- to 9-day-
old IrpAlfp-Cre(+) mice (B, D, F, H, J, and L) compared to control littermates (A, C,
E, G, I, and K).
(A–D) Periodic acid Schiff (PAS) staining reveals numerous vacuoles in the liver
of IrpAlfp-Cre(+) mice, typical of steatosis. Original magnifications: (A and B) 203,
(C and D), 403.
(E and F) TUNEL staining showing increased cell death (dark brown cells,
counterstain: hemalaun) in IRP-deficient livers. Original magnification: 403.
(G and H) Electron micrographs showing abundant lipid droplets in the liver of
mutant mice.
(I–L) At high magnification, mitochondria in IRP-deficient hepatocytes (J)
appear large and pale with poor cristae structure (red arrows) as compared
to control (I). They occasionally contain myelin-like structures that are not
present in control cells. An intact canaliculus (indicated Ca) is shown in (J).
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infiltrates (Figures 2A and 2B), TUNEL staining revealed
increased cell death in IRP-deficient livers (Figure 2F). Several
observations point to compromised liver function/integrity: (1)
a tendency for decreased albumin concentration and a signifi-
cant reduction in plasma protein levels (Table 1), (2) signs of
internal bleeding in the intestine and/or the brain of some
moribund animals (Figures 1G and 1H) plausibly due to inade-
quate hemostasis, and (3) increased serum alanine aminotrans-
ferase and aspartate aminotransferase (Table 1). Furthermore,
increased plasma alkaline phosphatase and conjugated bilirubin
indicate posthepatic cholestasis, although the bile canaliculi
themselves appear ultrastructurally normal in shape and number
(Figure 2J). Collectively, these data show that the early lethality of
mice with hepatocytic IRP deficiency is unrelated to Hepcidin
dysregulation or systemic abnormalities of iron metabolism but
likely results from hepatic failure. Hepatocytic IRP expression
thus appears to be indispensable for liver function and organ-
ismal survival.Mitochondriopathy in IRP-Null Livers
Hepatic steatosis could have multiple causes affecting lipid
synthesis, catabolism, and/or trafficking; mitochondrial dysfunc-
tion has emerged as a key feature of the pathogenesis of
fatty liver diseases (Mantena et al., 2008). Consistent with this,
mitochondriopathy represents the most prominent ultrastruc-
tural abnormality associated with persistent lipid accumulation
in IRP-deficient hepatocytes. Mitochondria are swollen,
imposing with a hypodense matrix and poor cristae structure
(Figure 2J), occasionally showing myelin-like figures (Figure 2L);
the other cellular organelles and structures appear normal.
To explore the cause(s) of the mitochondrial abnormalities in
IRP deficiency, we assayed enzymatic activities of the electron
transport chain (ETC) and the tricarboxylic acid (TCA) cycle.
The activity of complexes I, II, and III of the ETC (Figure 3A) is
markedly reduced, whereas complex IV is unaltered and ATP
synthase activity slightly increased. The ETC in the heart is intact
(Figure 3A), showing that the impairment of complexes I–III is
liver specific and not systemic. Likewise, analysis of TCA cycle
enzymes (Figure 3B) reveals a dramatic drop in the activity of
the 2-oxoglutarate dehydrogenase complex and significantly
altered citrate synthase, pyruvate dehydrogenase complex,.
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tion of total aconitase activity (mitochondrial plus cytosolic =
IRP1) reflects the lack of IRP1 and, likely, impaired function of
the mitochondrial isoform. These data show that IRP deficiency
in hepatocytes affects two of the central metabolic functions of
mitochondria, the ETC and the TCA cycle.
Mitochondrial Iron Deficiency and Compromised Heme
and ISC Biogenesis
What links the IRP/IRE system to mitochondrial function? Both
iron excess and deficiency may cause mitochondrial impairment
(Atamna et al., 2002). We therefore assayed total nonheme iron
levels in whole-liver extracts and found an 50% reduction in
IrpAlfp-Cre(+) mice (Figure 3C). To better understand the cause(s)
for decreased hepatic iron content, we analyzed the expression
of iron-related genes, focusing on IRP targets. As expected, IRP
ablation strongly enhances the posttranscriptional expression of
both the ferritin H and L chains and leads to a marked decrease
in the protein and mRNA levels of transferrin receptor 1 (TFRC)
(Figures S3A and S3B). FPN is also posttranscriptionally
increased, whereas the IRE-containing SLC11A2 (solute carrier
family 11 member 2)/DMT1 mRNA variant is downregulated.
Although not a direct IRP target, the expression of the mRNA
encoding the putative nontransferrin-bound iron uptake mole-
cule SLC39A14 (solute carrier family 39 member 14)/ZIP14
(Liuzzi et al., 2006) is also reduced (Figure S3C). The expression
of IRE-containing genes not directly involved in the control of
hepatocytic iron fluxes was analyzed as well (data presented in
Figure S3). Upregulation of the iron exporter FPN combined
with downregulation of iron acquisition molecules (TFRC,
SLC11A2, SLC39A14) can explain the reduction of the total
hepatic iron content in IrpAlfp-Cre(+) mice. Because mitochondrial
iron overload can coexist with cytosolic iron depletion and vice
versa (Paradkar et al., 2009; Shaw et al., 2006; Tong andRouault,
2006) and becausemitochondria appear to contribute a relatively
small fraction of total liver iron at a given time, at least in adult rats
(Swick et al., 1982), we also determined iron levels in isolated
mitochondria (Figure S4A) and found an 50% reduction in
IRP-null livers (Figure 3D). The IRP/IRE system thus controls
iron management proteins, which is critical for securing mito-
chondrial iron supplies. Of note, the SLC25A28 (a.k.a. mitoferrin
2) mitochondrial iron uptake molecule is severely downregulated
in IRP deficiency, whereas expression levels of its SLC25A37
(a.k.a. mitoferrin 1) paralog remain unchanged (Figures S4A
and S4B); this alteration most probably represents an indirect
effect of IRP deficiency, as SLC25A28mRNA bears no recogniz-
able IRE-like motif. Although the importance of SLC25A28
for mitochondrial iron uptake in mouse hepatocytes has not
yet been formally assessed, SLC25A28 downregulation in
IrpAlfp-Cre(+) animals would be expected to contribute to the
observed mitochondrial iron deficiency.
We next asked how mitochondrial iron deficiency affects
cellular physiology. Mitochondria convert iron into essential
bioactive prosthetic groups, i.e., heme and iron sulfur clusters
(ISC) that are utilized both by the mitochondrion itself and
throughout the cell (Levi and Rovida, 2009; Sheftel and Lill,
2009). Complexes I–III (ETC) and ACO2 (TCA cycle) are depen-
dent on ISC; impairment of their activity in IRP-deficient livers
(Figures 3A and 3B) could therefore be a sign of altered ISCCelmetabolism. Supporting this notion, the activities of the extrami-
tochondrial ISC protein xanthine dehydrogenase and the
mitochondrial ferrochelatase are also reduced by 75% and
90%, respectively, associated with only a minor decrease
(25%) in the steady-state levels of the corresponding proteins
(Figures 3E and 3F). We also observe decreased expression
of mature phosphoribosyl pyrophosphate amidotransferase
(PPAT) (Figure S4C), a cytosolic protein whose processing
requires the assimilation of an ISC. These data show that IRP
deficiency impairs both mitochondrial and extramitochondrial
ISC proteins, probably as a consequence of impaired ISC
biogenesis in mitochondria.
Ferrochelatase catalyzes the insertion of iron into protopor-
phyrin to form heme; hence, decreased ferrochelatase activity
(see above) combined with mitochondrial iron deficiency should
both negatively affect heme biosynthesis (Ajioka et al., 2006).
Indeed, heme levels are reduced in the liver of IrpAlfp-Cre(+)
mice, with the expected concomitant protoporphyrin accumula-
tion (Figure 3G); the accumulated protoporphyrin is essentially
free, with no detectable Zn-protoporphyrin. The ETC complex
IV is a hemoprotein; in spite of decreased heme levels, its activity
is not altered in IRP-null livers (Figure 3A). Similarly, the activity of
catalase, an extramitochondrial hemoprotein, is preserved
(Figure 3H). Although nonhepatocytic liver cells could mitigate
the effect of hepatocytic IRP deficiency in whole-tissue mea-
surements, these data are consistent with the reported preserva-
tion of the heme regulatory pool in Fechm1Pas mice expressing
less than 5% of normal liver ferrochelatase activity (Davies
et al., 2005); it appears that ferrochelatase is in significant
excess in liver cells, as opposed to erythroblasts in which the
enzyme is limiting (Puy et al., 2010). Although we cannot rule
out that other heme-dependent molecules could be affected,
the data suggest that ISC proteins are more sensitive to IRP defi-
ciency than hemoproteins andmight thus represent the ‘‘Achilles
heel.’’ Collectively, these data show that IRP deficiency causes
mitochondrial dysfunction with mitochondrial iron deficiency
and ensuing alterations of the ISC and heme biosynthetic path-
ways (Figure 3I).
Themarkedmitochondrial dysfunction in IrpAlfp-Cre(+) micewith
only a 2-fold reduction of total liver iron levels contrasts with
previous reports that also showed mitochondrial enlargement
in the liver of rats subjected to dietary iron restriction (Dallman
and Goodman, 1970) but largely preserved mitochondrial func-
tion (e.g., Dallman, 1986). Many studies have shown remarkable
resistance of liver mitochondria to iron deficiency unless rigid
regimen made animals severely anemic with a strong depletion
of the hepatic iron stores (e.g., Masini et al., 1994). As our
iron measurements include all liver cells, the contribution of non-
hepatocytes may partially mask a more severe reduction of
hepatocytic iron levels. More importantly, the physiological
response to iron deficiency is IRP activation and ferritin down-
regulation (see, e.g., Chen et al., 1997). In IRP-deficient hepato-
cytes, ferritin expression is completely derepressed in spite of
iron deficiency. The failure of IRP-null hepatocytes to decrease
iron sequestration in ferritin in the context of low iron levels
would therefore be predicted to further limit cellular iron bioavail-
ability, thereby creating a state of functional iron deficiency more
drastic than indicated by measurements of total liver iron. If
true, co-ablation of ferritin together with IRPswould be predictedl Metabolism 12, 194–201, August 4, 2010 ª2010 Elsevier Inc. 197
Figure 3. Mitochondrial Iron Deficiency and Function Associated with Altered Iron Sulfur Cluster and Heme Metabolism in IRP-Deficient
Livers
(A–H) Multiple biochemical parameters were assayed in liver samples of 8-day-old IrpAlfp-Cre(+) mice (gray bars) versus control IrpAlfp-Cre() littermates (open bars):
enzymatic activities of (A) the electron transport chain (left, liver; right, heart) and (B) the TCA cycle; nonheme iron levels in (C) the entire liver or (D) isolated
mitochondria; activity and expression levels of (E) xanthine dehydrogenase (XDH), (F) ferrochelatase (FECH), and (H) catalase (CAT); and heme and free
protoporphyrin (PPIX) levels (G). Data are presented as means ± SEM. The sample size (n) is indicated. p values were determined by Student’s t test.
CI (complex I), NADH-ubiquinone oxidoreductase; CII (complex II), succinate dehydrogenase; CIII (complex III), ubiquinol-cytochrome c oxidoreductase; CIV
(complex IV), cytochrome c oxidase; PDHc, pyruvate dehydrogenase complex; CS, citrate synthase; ACO, aconitase 2; IDH, isocitrate dehydrogenase; OGDHc,
oxaloglutarate dehydrogenase complex; MDH, malate dehydrogenase; FH, fumarate hydratase; Nd, not detectable.
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IRPs Are Essential for Mitochondrial Functionto (partially) alleviate the mitochondrial iron deficiency of
IrpAlfp-Cre(+) mice.
Recent studies of human genetic diseases and animal models
havehighlighted the importanceofmitochondrial ironmetabolism
(Levi and Rovida, 2009; Sheftel and Lill, 2009). This is exemplified
by the mitochondrial iron loading in pathologies associated with
abnormal ISCmetabolism such as Friedreich’s ataxia, themyop-
athy due to ISCU deficiency, or sideroblastic anemias due to
defects in e.g., the Grx5, Slc25A38, or Abcb7 genes (Guernsey
et al., 2009; Levi andRovida, 2009;Rouault andTong, 2008;Shef-
tel and Lill, 2009). It has been hypothesized that impaired ISC
biogenesis causes missignaling of the mitochondrial iron status,
causing increased mitochondrial iron uptake and/or decreased
efflux (Huang et al., 2009, Tong and Rouault, 2006).
IRP-deficient hepatocytes display decreased cellular iron
uptake (TFRC, SLC11A2, and SLC39A14) combined with
increased sequestration within ferritin and efflux via FPN. These
alterations decrease iron availability, limiting mitochondrial
iron supplies. In addition, IRP deficiency leads to reduced
SLC25A28 expression, which may further limit mitochondrial
iron uptake as observed in mitoferrin-deficient cells (Paradkar
et al., 2009; Shaw et al., 2006), resulting in impaired heme and
ISC metabolism and mitochondrial dysfunction (Figure 3I) with
widespread alterations of iron-containing proteins throughout
the cell. Furthermore, the lack of IRPs precludes the normal
response to impaired ISC biogenesis, which is IRP-mediated
adjustment of cellular iron uptake, storage, and export (Tong
and Rouault, 2006). In the absence of IRPs, mitochondria fail
to combat iron deficiency. The same mechanism could explain
the mitochondriopathy recently observed in enterocytes lacking
IRP expression (Galy et al., 2008; Smith et al., 2006), and we
propose that it represents a general function of IRPs in cell
biology.
By contrast, impaired ISC biogenesis with abnormally high IRP
activity appears to maintain cellular iron levels constitutively
high, triggering mitochondrial iron (over)loading. Whether and
how mitochondria can protect themselves against iron overload
remains to be elucidated. This work shows that IRP function
protects mitochondria against detrimental iron deficiency, a vital
mechanism that, at least in cases of, e.g., Friedreich’s ataxia,
appears to override the hypothetical protective measures
against mitochondrial iron overload.EXPERIMENTAL PROCEDURES
Mice
For all studies of IrpAlfp-Cre(+) mice, controls consisted of IrpAlfp-Cre() litter-
mates. Mice were backcrossed to C57BL6 mice for at least 10 generations.
Whereas 4-day-old IrpAlfp-Cre(+) mice displayed normal mitochondrial ultra-
structure and no histological sign of apoptosis, mitochondriopathy appeared
in 6-day-old animals and was fully penetrant at 8 days of age (data not shown).
Hence, all assays were carried out using 8-day-old animals. Mice were kept
under a constant light/dark cycle on a standard diet. They were sacrificed
by CO2 inhalation, and heparinized blood was collected by cardiac puncture.
Animal handling was in accordance with approved EMBL guidelines.(I) Model illustrating the central role of the IRP/IRE system for mitochondrial iron s
and heme) to sustain their own needs as well as supplying heme and (presuma
storage, IRPs secure sufficient cytosolic iron availability for mitochondrial import
See also Figures S3 and S4.
CelHematology and Blood Chemistry
Hematological and plasma iron parameters were determined as described
previously (Galy et al., 2008). Plasma alanine aminotransferase and aspartate
aminotransferase levels, respectively, were determined using the ALT/TGP
and AST/TGO kits (Biolabo, Maizy, France). All other plasma chemistry param-
eters were determined by the Claude Bernard Institute Chemistry Laboratory
(Paris, France) using an Olympus 400 analyzer.
Measurement of Hepatic Triglyceride Levels
Lipids were extracted from liver homogenates with chloroform:methanol (2:1)
and, after dessication, resuspended in isopronanol + 10% Triton X-100 as
described (Yang et al., 2009). TG were assayed spectrophotometrically using
the TG/GPO kit (Biolabo). TG levels were standardized to protein levels in
the initial homogenate as determined using the DC protein assay (BioRad,
Mu¨nchen, Germany).
Immunoblotting
Tissues were pulverized in liquid nitrogen and homogenized in RIPA buffer
complemented with inhibitors of proteases (Galy et al., 2005b) and of
phosphatases (phosphatase inhibitor cocktail 2, Sigma-Aldrich, Taufkirchen,
Germany). Lysates were incubated for 30 min on ice and centrifuged at
14,500 3 g for 15 min at 4C. The supernatant was stored at 80C until
use. For immunodetection of EPAS1 and LAMIN-A, the pellet was resus-
pended in 20 mM HEPES (pH 7.4), 400 mM NaCl, and 1 mM EDTA + protease
inhibitors and incubated for 30 min on ice. After sonication in a Bioruptor
(Diagenode, Lie`ge, Belgium), debris was pelleted by centrifugation at
14,5003 g for 20min at 4C. Immunoblotting was performed using the primary
antibodies listed in Supplemental Experimental Procedures, together with
HRP-conjugated secondary antibodies. For quantification of CAT, FECH,
PPAT, and XDH expression, we used fluorescently labeled secondary
antibodies together with an Odyssey infrared imaging system (LI-COR Biosci-
ences GmbH, Homburg, Germany); CAT, FECH, PPAT, and XDH levels were
calibrated to b-ACTIN expression.
Enzymatic Assays
Catalase
Liver tissues were homogenized in 50 mMKPO4 (pH 7.0) and 1 mM EDTA, and
debris was pelleted by centrifugation at 10,0003 g for 15 min at 4C. Enzyme
activity was measured using the catalase assay kit from Cayman (Cayman
Europe, Tallin, Estonia) and standardized to total protein concentration.
Xanthine Dehydrogenase
Tissueswere homogenized in 100mMKPO4 (pH 7.5), 2.5mMEDTA, and 5mM
DTT, and debris was pelleted by centrifugation at 10,0003 g for 20min at 4C.
100 mg of total protein were resolved by PAGE, and XDH activity was assayed
in gel as described (Lee et al., 2002). Signal intensity was determined using the
NIH Image program (http://rsb.info.nih.gov/nih-image/).
Ferrochelatase
Tissues were homogenized in 50 mM Tris-HCl (pH 7.6) and 20% glycerol, and
debris was pelleted by centrifugation at 300 3 g for 10 min at 4C. FECH
activity was determined by fluorometric monitoring of Zn-mesoporphyrin
synthesis as described (Lyoumi et al., 2007) and was expressed as nanomoles
of Zn-mesoporphyrin formed per hour per milligram of protein at 37C.
ETC and TCA Cycle
Tissues were homogenized in 20 mM Tris-HCl (pH 7.4), 250 mM sucrose,
50 mM KCl, and 5 mM MgCl2, and homogenates were centrifuged at 600 3
g for 10 min at 4C. Steady-state activity of ETC and TCA enzyme complexes
in the supernatant was determined as described (Sauer et al., 2005) using
a temperature-controlled computer-tunable spectrophotometer (Spectramax
Plus Microplate Reader, Molecular Devices, Sunnyvale, CA) operating in the
dual wavelength mode. The addition of standard respiratory chain inhibitors
was used to ascertain the specificity of the enzymatic assays. All enzymatic
activities were calibrated to protein concentration.ufficiency and function. Mitochondria convert iron into bioactive forms (i.e., ISC
bly) ISCs to the rest of the cell. By controlling cellular iron uptake, efflux, and
and subsequent utilization by the ISC and heme biosynthetic pathways.
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Total nonheme iron content of the liver was determined as described (Galy
et al., 2005b). For the determination of mitochondrial iron levels, fresh liver
samples were rinsed, finely minced, and homogenized in 4 ml of buffer A
(20 mM Tris-HCl [pH 7.4], 250 mM saccharose, 50 mM KCl, and 5 mM
MgCl2) using a Dounce homogenizer. The homogenate was centrifuged at
6003 g for 10 min. The pellet was resuspended in 10 ml of buffer A and centri-
fuged for 10 min at 3,000 3 g three times. The crude mitochondrial pellet was
resuspended in 100 ml of buffer A, and protein concentration was determined
using the DC protein assay (BioRad). 10 ml of mitochondrial suspension were
mixed with 90 ml of 10% HCl + 10% TCA and incubated overnight at 45C.
The samples were centrifuged for 10 min at 10,000 3 g, and the supernatant
was incubated for 10 min with five volumes of 7M Na acetate, bathophenan-
throline-disulfonic acid 0.01%, and thioglycolic acid 0.1%. The OD was
measured at 535 nm. For each sample, the blank absorbance was determined
by omitting the bathophenanthroline chromogen. The amount of iron was
inferred from the serial dilution of a standard iron solution (iron atomic
spectroscopy standard, Fluka, Sigma-Aldrich).
Measurement of Heme and Protoporphyrin Levels
The hepatic heme content was determined as described (Delaby et al., 2008).
Liver tissue was homogenized in 1:10 w/v ice-cold 50 mM phosphate buffer
(pH 7.5), and debris was pelleted by centrifugation at 10,000 3 g for 10 min
at 4C. The supernatant was diluted at a 1:5 ratio with saline and passed
through aC18 column (Varian, Les Ulis, France). After three washeswith water,
heme was eluted with formic acid and heme concentration was determined
spectrophotometrically at 400 nm using hemin (Orphan Europe; Paris, France)
as a standard. Protoporphyrin was extracted from liver tissue and quantified
by HPLC and fluorescence emission scanning using a RF540 spectrofluorim-
eter (Shimadzu Co) and a protoporphyrin standard (Frontier Scientific, Carn-
forth, Lancashire, UK) as described (Lyoumi et al., 2008).
Microscopy Analyses
For light microscopy, liver samples were fixed in formaldehyde and embedded
in paraffin. Periodic acid Schiff staining images were acquired using the
AxioVision 4.7.1 software and a Zeiss Imager D1 microscope equipped with
a AxioCamHRc camera (Zeiss, Jena, Germany). For electronmicroscopy, liver
samples were fixed in Karnovsky’s solution and embedded in araldite. Ultra-
thin sections were viewed using a Zeiss 900 electron microscope.
Statistical Analyses
Differences between mean values were evaluated by two-tailed Student’s
t test using the Prism software (GraphPad Software, La Jolla, CA). A p value <
0.05 was considered significant.
SUPPLEMENTAL INFORMATION
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